The Expressions of Wnt/β-catenin Pathway-Related Components in Brainstem Gliomas

Canadian Journal of Neurological Sciences

Volumn 40, Issue 3, 2013, Pages 355-360

  wu, Wenhao ^a   Tian, Yongji ^a   Wan, Hong ^b   Song, Yongmei ^a   li, Junhua ^b   Zhang, Liwei ^a  

^a CANCER HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; KI 67 ANTIGEN; MYC PROTEIN; MYC PROTEIN, HUMAN; WNT PROTEIN;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BRAIN STEM; BRAIN STEM TUMOR; CHILD; FEMALE; GENE EXPRESSION REGULATION; GLIOMA; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BETA CATENIN; BRAIN STEM; BRAIN STEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; WNT PROTEINS; YOUNG ADULT;

EID: 84888867332     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S031716710001430X     Document Type: Article

References (22)

1. Laigle-Donadey, F, Doz, F, Delattre, JY. Brainstem gliomas in children and adults. Curr Opin Oncol. 2008; 20(6):662–7.
2. Rosenthal, MA, Ashley, DM, Drummond, KJ, et al. Brain stem gliomas: patterns of care in Victoria from 1998-2000. J Clin Neurosci. 2008; 15(3):237–40.
3. Liu, YL, Yang, HP, Zhou, XD, Gong, L, Tang, CL, Wang, HJ. The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-small-cell lung cancer. Curr Cancer Drug Targets. 2011; 11(9):1098–110.
4. Yang, L, Chen, Y, Cui, T, et al. Desmoplakin acts as a tumour suppressor by inhibition of the Wnt/β-catenin signalling pathway in human lung cancer. Carcinogenesis. 2012; 33(10):1863–70.
5. Yeh, CT, Rao, YK, Ye, M, et al. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging. Toxicol Appl Pharmacol. 2012; 261(1):31–41.
6. Mehta, VS, Chandra, PS, Singh, PK, Garg, A, Rath, GK. Surgical considerations for ‘intrinsic’ brainstem gliomas: proposal of a modification inclassification. Neurol India. 2009; 57(3):274–81.
7. Mohanty, A. Role of surgery in brainstem gliomas. Neurol India. 2009; 57(3):231–2.
8. Bartels, U, Hawkins, C, Vézina, G, Kun, L, Souweidane, M, Bouffet, E. Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG. J Neurooncol. 2011; 105(1):119–25.
9. Chassot, A, Canale, S, Varlet, P, et al. Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol. 2012; 106(2):399–407.
10. Kang, YJ, Park, HJ, Chung, HJ, et al. Wnt/β-Catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells. Mol Pharmacol. 2012; 82(2):168–77.
11. Pacheco-Pinedo, EC, Durham, AC, Stewart, KM, et al. Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. J Clin Invest. 2011; 121(5):1935–45.
12. Lachenmayer, A, Alsinet, C, Savic, R, et al. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clin Cancer Res. 2012; 18(18):4997–5007.
13. Asuthkar, S, Gondi, CS, Nalla, AK, Velpula, KK, Gorantla, B, Rao, JS. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-cateninsignaling is enhanced in irradiated medulloblastoma cells. J Biol Chem. 2012; 287(24): 20576–89.
14. Cimmino, F, Scoppettuolo, MN, Carotenuto, M, et al. Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling. J Neurooncol. 2012; 106(1):59–70.
15. Baryawno, N, Sveinbjörnsson, B, Eksborg, S, Chen, CS, Kogner, P, Johnsen, JI. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. Cancer Res. 2010; 70(1):266–76.
16. Zhang, N, Wei, P, Gong, A, et al. FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell. 2011; 20(4):427–42.
17. Rossi, M, Magnoni, L, Miracco, C, et al. β-catenin and gli1 are prognostic markers in glioblastoma. Cancer Biol Ther. 2011; 11(8):753–61.
18. Kahlert, UD, Maciaczyk, D, Doostkam, S, et al. Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. Cancer Lett. 2012; 325(1):42–53.
19. Logan, CY, Nusse, R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004; 20: 781–810.
20. Liu, C, Tu, Y, Sun, X, et al. Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations. Clin Exp Med. 2011; 11(2):105–12.
21. Pu, P, Zhang, Z, Kang, C, et al. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther. 2009; 16(4):351–61.
22. Sareddy, GR, Panigrahi, M, Challa, S, Mahadevan, A, Babu, PP. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int. 2009; 55(5):307–17.